INDP - Indaptus Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

INDP is currently covered by 2 analysts with an average price target of $9.53. This is a potential upside of $6.91 (263.74%) from yesterday's end of day stock price of $2.62.

Indaptus Therapeutics's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of INDP is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for INDP is $12, Lowest price target is $8, average price target is $9.53.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 06-Nov-2023. First documented stock forecast 20-Oct-2021.

Best performing analysts who are covering INDP - Indaptus Therapeutics:

Raghuram Selvaraju Jason Mccarthy

Currently out of the existing stock ratings of INDP, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$5.61 (234.73%)

4

5 months 10 days ago

0/3 (0%)

$5.32 (198.51%)

Buy

12

$9.61 (402.09%)

6 months 27 days ago

0/2 (0%)

$8.5 (242.86%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INDP (Indaptus Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on INDP (Indaptus Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on INDP (Indaptus Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?

Raghuram Selvaraju has 3 price targets and 21 ratings on INDP

Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?

Raghuram Selvaraju with highest potential upside - $9.61

Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?

Jason Mccarthy with lowest potential downside - $5.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?